Stay updated on Ipilimumab Nivolumab in Small Cell Lung Cancer Clinical Trial
Sign up to get notified when there's something new on the Ipilimumab Nivolumab in Small Cell Lung Cancer Clinical Trial page.

Latest updates to the Ipilimumab Nivolumab in Small Cell Lung Cancer Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedThe page now shows a recruitment notice 'No longer looking for participants' and adds navigation/help sections (How to Read a Study Record, Common Questions, How to Join a Study) alongside an updated Intervention/Treatment label. The older 'Intervention / Treatment' text and 'Revision: v3.5.5' have been removed, with the page revision updated to v3.6.0.SummaryDifference0.5%

- Check16 days agoChange DetectedThe page now displays Revision: v3.5.5, replacing the previous v3.5.4, indicating a small page/template update. No study content or user-facing details have been changed.SummaryDifference0.1%

- Check38 days agoChange DetectedRevision tag updated to v3.5.4, indicating a software/documentation update, replacing the previous v3.5.3. No visible study content or page functionality changes are indicated.SummaryDifference0.1%

- Check60 days agoChange DetectedUpdated the site’s release/revision label for the ClinicalTrials.gov page from v3.5.2 to v3.5.3.SummaryDifference0.1%

- Check67 days agoChange DetectedRevision: v3.5.2 added, replacing the previous v3.5.0.SummaryDifference0.1%

- Check81 days agoChange DetectedAdded a resources section linking to the Genetic and Rare Diseases Information Center and included 'Small cell lung carcinoma' as a related term on the page.SummaryDifference0.2%

Stay in the know with updates to Ipilimumab Nivolumab in Small Cell Lung Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Ipilimumab Nivolumab in Small Cell Lung Cancer Clinical Trial page.